Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.80p +1.25% 64.60p 249,076 13:18:00
Bid Price Offer Price High Price Low Price Open Price
64.00p 65.00p 66.80p 64.00p 64.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 103.32 28.37 6.10 10.6 334.8

Alliance Pharma (APH) Latest News

More Alliance Pharma News
Alliance Pharma Takeover Rumours

Alliance Pharma (APH) Share Charts

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Intraday Alliance Pharma Chart

Intraday Alliance Pharma Chart

Alliance Pharma (APH) Discussions and Chat

Alliance Pharma Forums and Chat

Date Time Title Posts
21/3/201921:58Alliance Pharma pays Dividends1,426
21/8/201816:36A Canadian Stock Worth Watching1
11/6/201809:21Unexpected-
07/11/201615:35Alliance Pharma plc1
15/7/201309:15ALLIANCE PHARMA – 2005 Strong Riser611

Add a New Thread

Alliance Pharma (APH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:11:3664.60510329.46AT
13:11:3664.60886572.36AT
13:11:3664.201,6431,054.81AT
13:11:3664.201,6201,040.04AT
13:11:3664.201,7361,114.51AT
View all Alliance Pharma trades in real-time

Alliance Pharma (APH) Top Chat Posts

DateSubject
25/3/2019
08:20
Alliance Pharma Daily Update: Alliance Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 63.80p.
Alliance Pharma has a 4 week average price of 62p and a 12 week average price of 59.20p.
The 1 year high share price is 102.50p while the 1 year low share price is currently 59.20p.
There are currently 518,230,255 shares in issue and the average daily traded volume is 1,212,597 shares. The market capitalisation of Alliance Pharma is £336,849,665.75.
19/3/2019
15:38
saeed45: What should we expect on the share price from the announcement next week?
15/3/2019
08:52
winnings1: Every reduction in a major holding has to be announced to the Market, In the absence of any such announcements, the explanation for the stubborn low share price could be impatient fickle private investors selling on minor rises looking for a fast buck elsewhere....at a risk of a fast loss. APH is a steady horse, growing at a steady rate, perhaps somewhat boring but safer than most. However, the low share price will not be forever, a positive RNS from APH (could come anytime) will drive the share price substantially north. IMO, Winnings.
07/3/2019
18:18
winnings1: APH's shares continue to trade below 70p, yet realistically and based on fundamentals the shares deserve to trade above 80p. I hold long term, therefore I am not unduly perturbed at the current under-performance of the share price which in my view is unlikely to last for very much longer.
29/1/2019
13:06
saeed45: Brexit talks today.. may have an influence on share price for short term holders
21/1/2019
14:05
winnings1: Share price likely to work ii's way to 75p+, perhaps 80p+, where it belongs to be.
21/1/2019
07:47
winnings1: Trading Update today (se3e RNS) looks good to me, I expect we shall see the share price react positively and rise substantially over the coming days/weeks.
15/1/2019
13:56
winnings1: Whatever the reason for sellers exceeding buyers, the Company's performance is unaffected. I hold a good number of shares, I have no intentions to sell, I maintain the shares are worth 80p+ and I maintain that share price recovery is inevitable as there is no knowledge nor expectation of deterioration in the company's performance. Cheers.
18/10/2018
15:36
cisk: Livingbridge aren’t even a major shareholder, there has been no RNS re their holding, I don’t think they were even over 3% and I’m sorry I’m not going to sit through their webinar to find out what they said. For those that are concerned, take a look at Livingbridge’s top 10 holdings - nothing much to write home about. And they mirror their benchmark and I wouldn’t say their performance is spectacular. So I just don’t see the performance of an average fund impacting the share price to that extent. So personally I care not a jot what this fund does. I do care about upcoming launches and the pending good news flow coming from the company, and Nizoral sales getting going and feeding through to the bottom line. Really the share price got ahead of itself this year, it’s probably oversold now but it’s an opportunity to top up, if you feel like doing so in the current market. Alliance has grown steadily, and through deals etc it’s not as reliant on a single product as it once was.
18/10/2018
11:13
winnings1: Remarkable how low the share price of APH has gone (65p-66p today). In the current uncertain times (political and financial) the shares of APH should be at a premium as the Company operates in recession proof territory, Demand for medicines will continue to go up, whatever the state of the global economy.
24/7/2017
09:24
arf dysg: I notice that the International Misery Fund said that we're screwed, blued and tattooed. Putting it in slightly more formal language, the predictions for growth in the USA and the UK have gone down a little. Perhaps that's why everyone's taking drugs as if there's no tomorrow, so the APH share price has gone up.
Alliance Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190325 13:40:18